Industry reports
Editor highlights

Search inside this page

Publishers

Free Market Research Guides to Download

Pharmaceutical Analysis & Statistics in North America Countries, May 2013 (p57)

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

1681-1730 of about 7 300 reports
OTC Pharmaceuticals - Top 5 Emerging Industries Market Overview (Market size, Segmentation and Trends Analysis)

OTC Pharmaceuticals - Top 5 Emerging Industries Market Overview (Market size, Segmentation and Trends Analysis)

  • $ 995
  • Industry report
  • August 2013
  • by MarketLine

The report includes easily comparable data on industry value, volume, sector ation and industry share, plus full five year industry projections . It examines future problems, innovations and potential ...

  • Industries : Over-the-counter Drug
  • Countries : India, South Africa, Brazil, China, Mexico
Diabetes: Battle for ascendancy escalates in expanding market - KOL Insight

Diabetes: Battle for ascendancy escalates in expanding market - KOL Insight

  • $ 5 360
  • Industry report
  • August 2013
  • by Firstword Pharma

Diabetes is one of the few disease areas that has retained its market value despite the entry of generics, the rise in drug prices and prevalence of the disease has allowed drug sales to soar to a worldwide ...

  • Industries : Pathology
  • Countries : United States
Cancer Genetics, Inc. (CGIX) - Medical Equipment - Deals and Alliances Profile

Cancer Genetics, Inc. (CGIX) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2013
  • by Global Data

Summary Cancer Genetics, Inc. (CGI) is the leader in the field of personalized medicine. It offers cancer diagnostics and treatments tailoring the specific genetic profile of the individual. The diagnostic ...

  • Industries : Pathology
  • Countries : United States
Salix Pharmaceuticals Ltd. (SLXP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Salix Pharmaceuticals Ltd. (SLXP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2013
  • by Global Data

Summary Salix Pharmaceuticals Ltd. (Salix) is a specialty pharmaceutical company. It develops and markets prescription pharmaceutical products for the prevention and treatment of gastrointestinal diseases. ...

  • Industries : Pharmaceutical
  • Countries : United States, World
VGX Pharmaceuticals Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

VGX Pharmaceuticals Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2013
  • by Global Data

Summary VGX Pharmaceuticals Inc. is a leading biopharmaceutical company with strong product candidates for the treatment of infectious diseases including HIV as well as cancer and inflammatory diseases. ...

  • Industries : Pharmaceutical
  • Countries : United States
Urigen Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Urigen Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2013
  • by Global Data

Summary Urigen Pharmaceuticals, Inc. (Urigen) is a specialty pharmaceutical company that develops and commercializes therapeutic products for urological disorders. The company's research and development ...

  • Industries : Pharmaceutical
  • Countries : United States
Zoticon Bioventures - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Zoticon Bioventures - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2013
  • by Global Data

Summary Zoticon Bioventures is a drug development company and an investment firm which invests in healthcare companies. It is based in Pennsylvania, USA. Zoticon Bioventures - Pharmaceuticals & Healthcare ...

  • Industries : Therapy
  • Countries : United States
Valensa International - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Valensa International - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2013
  • by Global Data

Summary Valensa International is a biopharmaceutical company that discovers, develops, and provides science-based botanical sourced products for human health and well-being. It offers products in the areas ...

  • Industries : Pharmaceutical
  • Countries : United States, World
Therapies and Diagnostics for Cervical Cancer

Therapies and Diagnostics for Cervical Cancer

  • $ 6 650
  • Industry report
  • August 2013
  • by BCC Research

STUDY GOALS AND OBJECTIVES This report provides an overview of the current and potential global market for cervical cancer, including treatments and screening and testing technologies. The report provides ...

  • Industries : Pathology
  • Countries : World, United States
Physician Views: Can GlaxoSmithKline strike early with Anoro? / What role will dosing, inhaler type play in uptake of LAMA/LABA combinations for COPD?

Physician Views: Can GlaxoSmithKline strike early with Anoro? / What role will dosing, inhaler type play in uptake of LAMA/LABA combinations for COPD?

  • $ 645
  • Industry report
  • August 2013
  • by Firstword Pharma

Scope This year looks set to be one of notable evolution for the US chronic obstructive pulmonary disease (COPD) market and GlaxoSmithKline's respiratory franchise in particular. The company secured FDA ...

  • Industries : Drug Delivery Technology
  • Countries : United States
Physician Views: Which diabetes company does the best marketing job? What is key for companies launching products?

Physician Views: Which diabetes company does the best marketing job? What is key for companies launching products?

  • $ 645
  • Industry report
  • August 2013
  • by Firstword Pharma

Scope The importance of marketing is increasingly coming to the fore as diabetes-focused companies battle for market superiority. AstraZeneca, Merck & Co. and Novo Nordisk have all expanded their diabetes ...

  • Industries : Pathology
  • Countries : United States, Spain, Italy, France, Germany, United Kingdom, Europe
Physician Views: Will generic Copaxone have traction in the MS market given emergence of oral therapies?

Physician Views: Will generic Copaxone have traction in the MS market given emergence of oral therapies?

  • $ 731
  • Industry report
  • August 2013
  • by Firstword Pharma

Scope A recent ruling by the US Court of Appeals for the Federal Circuit has increased the likelihood of generic competition to Teva's multiple sclerosis treatment Copaxone entering the market in May 2014, ...

  • Industries : Therapy
  • Countries : United States
Pulmonary Hypertension - Pipeline Review, H2 2013

Pulmonary Hypertension - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Pulmonary Hypertension - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Pulmonary Hypertension - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. ...

  • Industries : Therapy
  • Countries : World, United States
Fungal Infections - Pipeline Review, H2 2013

Fungal Infections - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Fungal Infections - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Fungal Infections - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Drug and Medication
  • Countries : United States, World
Helicobacter Pylori Infections - Pipeline Review, H2 2013

Helicobacter Pylori Infections - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Helicobacter Pylori Infections - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Helicobacter Pylori Infections - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic ...

  • Industries : Pathology
  • Countries : Japan, World, United States
Refractory Multiple Myeloma - Pipeline Review, H2 2013

Refractory Multiple Myeloma - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Refractory Multiple Myeloma - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Refractory Multiple Myeloma - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic ...

  • Industries : Pathology
  • Countries : United States, World
Diabetic Gastroparesis - Pipeline Review, H2 2013

Diabetic Gastroparesis - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Diabetic Gastroparesis - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Diabetic Gastroparesis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. ...

  • Industries : Pathology
  • Countries : World, United States, Portugal
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2013

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline ...

  • Industries : Therapy
  • Countries : United States
Psychosis - Pipeline Review, H2 2013

Psychosis - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Psychosis - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Psychosis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...

  • Industries : Therapy
  • Countries : United States, World, Germany
Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H2 2013

Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H2 2013', provides an overview of the indication's ...

  • Industries : Pathology
  • Countries : Japan, World, United States
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2013

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2013', provides an overview ...

  • Industries : Pathology
  • Countries : World, United States
Neuroblastoma - Pipeline Review, H2 2013

Neuroblastoma - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Neuroblastoma - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Neuroblastoma - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : United States
Follicular Lymphoma - Pipeline Review, H2 2013

Follicular Lymphoma - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Follicular Lymphoma - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Follicular Lymphoma - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : United States, World
Kidney Fibrosis - Pipeline Review, H2 2013

Kidney Fibrosis - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Kidney Fibrosis - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Kidney Fibrosis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Therapy
  • Countries : World, United States, Canada, Japan, China
Injury - Pipeline Review, H2 2013

Injury - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Injury - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Injury - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...

  • Industries : Therapy
  • Countries : World, United States
Chronic Bronchitis - Pipeline Review, H2 2013

Chronic Bronchitis - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Chronic Bronchitis - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Chronic Bronchitis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : World, United States
Astrocytoma - Pipeline Review, H2 2013

Astrocytoma - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Astrocytoma - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Astrocytoma - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...

  • Industries : Pathology
  • Countries : World, United States
Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2013

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2013', provides an overview of the indication's ...

  • Industries : Pathology
  • Countries : World, United States, New Zealand, Australia
Hodgkin Lymphoma - Pipeline Review, H2 2013

Hodgkin Lymphoma - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Hodgkin Lymphoma - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Hodgkin Lymphoma - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : United States
Ischemia - Pipeline Review, H2 2013

Ischemia - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Ischemia - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Ischemia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...

  • Industries : Therapy
  • Countries : World, United States

» View Public Reports

About 15 000 reports

The United States: Demographic Analysis, 2014-2017

  • Country report
  • April 2014
  • 50 pages

... Related diseases to account for the low life expectancy and queried whether figures may improve, the longer the industry ceases to exist. In response, the director of public health confirmed that we could ...

U.s. Diabete Sector

April 2014

» Read our Company Profiles

About 200 Companies

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Biogen Idec

United States

Pfizer Inc.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.